Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Benner

Showing results (191-200 of 347) with videos related to

Pageof 35
Sort By:
The New England Journal of Medicine|May 3, 2008
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemiaRichard F Schlenk, Konstanze Döhner, Jürgen Krauter, et al.
Genome Biology|October 15, 2008
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomasFrank Westermann, Daniel Muth, Axel Benner, et al.
Cancer Research|September 17, 2005
T25 repeat in the 3' untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancerPeter Findeisen, Matthias Kloor, Sabine Merx, et al.
Cancer Biology & Therapy|January 23, 2009
Troglitazone-mediated sensitization to TRAIL-induced apoptosis is regulated by proteasome-dependent degradation of FLIP and ERK1/2-dependent phosphorylation of BADKerstin Grund, Rezvan Ahmadi, Fortunata Jung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2007
High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN statusFrank Westermann, Kai-Oliver Henrich, Jun S Wei, et al.
Haematologica|August 18, 2010
Protein expression analysis of chronic lymphocytic leukemia defines the effect of genetic aberrations and uncovers a correlation of CDK4, P27 and P53 with hierarchical riskDirk Winkler, Christof Schneider, Manuela Zucknick, et al.
Blood|February 29, 2008
Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instabilityTilmann Bochtler, Ute Hegenbart, Friedrich W Cremer, et al.
Genes, Chromosomes & Cancer|July 8, 2005
Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogeneticsFriedrich W Cremer, Jelena Bila, Isabelle Buck, et al.
International Journal of Molecular Sciences|November 4, 2020
Genotype-Based Gene Expression in Colon Tissue-Prediction Accuracy and Relationship with the Prognosis of Colorectal Cancer PatientsHeike Deutelmoser, Justo Lorenzo Bermejo, Axel Benner, et al.
American Journal of Hematology|April 12, 2021
Daratumumab, lenalidomide, and dexamethasone in systemic light-chain amyloidosis: High efficacy, relevant toxicity and main adverse effect of gain 1q21Christoph R Kimmich, Tobias Terzer, Axel Benner, et al.
Pageof 35

Showing results (191-200 of 347) with videos related to

Sort By:
Pageof 35
The New England Journal of Medicine|May 3, 2008
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemiaRichard F Schlenk, Konstanze Döhner, Jürgen Krauter, et al.
Genome Biology|October 15, 2008
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomasFrank Westermann, Daniel Muth, Axel Benner, et al.
Cancer Research|September 17, 2005
T25 repeat in the 3' untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancerPeter Findeisen, Matthias Kloor, Sabine Merx, et al.
Cancer Biology & Therapy|January 23, 2009
Troglitazone-mediated sensitization to TRAIL-induced apoptosis is regulated by proteasome-dependent degradation of FLIP and ERK1/2-dependent phosphorylation of BADKerstin Grund, Rezvan Ahmadi, Fortunata Jung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2007
High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN statusFrank Westermann, Kai-Oliver Henrich, Jun S Wei, et al.
Haematologica|August 18, 2010
Protein expression analysis of chronic lymphocytic leukemia defines the effect of genetic aberrations and uncovers a correlation of CDK4, P27 and P53 with hierarchical riskDirk Winkler, Christof Schneider, Manuela Zucknick, et al.
Blood|February 29, 2008
Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instabilityTilmann Bochtler, Ute Hegenbart, Friedrich W Cremer, et al.
Genes, Chromosomes & Cancer|July 8, 2005
Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogeneticsFriedrich W Cremer, Jelena Bila, Isabelle Buck, et al.
International Journal of Molecular Sciences|November 4, 2020
Genotype-Based Gene Expression in Colon Tissue-Prediction Accuracy and Relationship with the Prognosis of Colorectal Cancer PatientsHeike Deutelmoser, Justo Lorenzo Bermejo, Axel Benner, et al.
American Journal of Hematology|April 12, 2021
Daratumumab, lenalidomide, and dexamethasone in systemic light-chain amyloidosis: High efficacy, relevant toxicity and main adverse effect of gain 1q21Christoph R Kimmich, Tobias Terzer, Axel Benner, et al.
Pageof 35